Erythromycin can be taken with or without food, but consuming it with a light meal may lessen gastrointestinal irritation. Food does not significantly alter the overall absorption of the drug.
A mild rash is a common side effect and may resolve without intervention. However, if the rash spreads, becomes blistered, or is accompanied by fever, seek medical attention promptly as it could signal a serious allergic reaction.
Brand tablets such as Erythrocin are typically round, white to off-white, and may be scored for splitting. Imprint codes vary by manufacturer; the packaging insert provides exact identification details.
Some herbal products, notably St John’s wort, can induce CYP enzymes and potentially reduce erythromycin levels, while others like grapefruit juice may increase its concentration. Inform your healthcare provider of all supplements you use.
Yes, but keep the medication in its original packaging with a copy of the prescription. The UK’s MHRA recommends carrying a letter from your doctor if you need to present the drug at customs.
Photosensitivity is not a common side effect of erythromycin, but some individuals may experience increased skin sensitivity to sunlight. If you notice unusual sunburns, protect exposed skin with clothing or sunscreen.
Erythromycin has a broader spectrum against certain atypical bacteria and can be used where azithromycin resistance is a concern. Cost and local formulary considerations may also influence the choice.
Both are oral formulations of the same active molecule. The ethylsuccinate salt improves solubility, allowing more flexible dosing regimens. Clinical efficacy is comparable.
Given its short half-life of 1.5-2 hours, erythromycin is usually eliminated within 12 hours after the last dose in individuals with normal liver function.
Erythromycin is not the first-line agent for animal bite prophylaxis; amoxicillin-clavulanate is preferred due to broader coverage of Pasteurella species.
Erythromycin is a macrolide antibiotic that is widely used to treat a variety of bacterial infections. This article covers erythromycin, available as a generic medication and marketed under brand names such as Erythrocin and Eryc in the United Kingdom. It is supplied as oral pill tablets in strengths of 250 mg and 500 mg and is classified as a prescription-only medicine (POM) under the regulations of the Medicines and Healthcare products Regulatory Agency (MHRA).
Erythromycin interferes with bacterial protein synthesis. It binds to the 50S subunit of the bacterial ribosome, blocking the translocation step that moves the growing peptide chain. This action stops the bacteria from producing essential proteins, leading to bacterial growth inhibition (bacteriostatic) at typical doses. In higher concentrations, erythromycin can become bactericidal, killing susceptible organisms.
Erythromycin is approved in the UK for the following indications:
These uses reflect the drug’s activity against Gram-positive cocci, certain Gram-negative bacilli, and atypical organisms such as Mycoplasma and Chlamydia species.
All off-label use requires medical supervision and an individualized risk-benefit assessment.
These effects are usually transient and may lessen with continued therapy.
Standard dosing:
250 mg tablets: Usually taken every 6 hours (four times daily) for most infections.
500 mg tablets: May be prescribed every 8 hours (three times daily) for more severe infections.
Special populations:
Hepatic impairment: Consider extending the dosing interval (e.g., every 8-12 hours) under clinical supervision.
Elderly: Start at the lower end of the dosing range and monitor for side effects.
Administration: Swallow tablets whole with a glass of water. Do not crush or chew unless a specific formulation advises otherwise.
Missed dose: Take the missed tablet as soon as you remember unless it is close to the time of the next scheduled dose; do not double up.
Overdose: Symptoms may include severe diarrhoea, vomiting, and abdominal pain. Seek urgent medical care; activated charcoal may be considered if presentation is early.
Discontinuation: For short courses (≤7 days) abrupt cessation is acceptable. Longer therapies may require tapering to avoid potential rebound effects in certain infections (e.g., H. pylori eradication).
This article provides educational information about erythromycin and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.